Spot on, ohm, with your questions.
I've seen the Netflix documentary "Dirty Money" recently (which was mainly about Valeant Pharma though), and my initial reaction was "What the..." when seeing that Turing was our partner... I hope these questions you put down have been addressed during negotiations and a realistic and fair price tag has been agreed on so that most patients can benefit from it (at least for me, that is important too...)
I see this as a deal with the devil, but as a kind of necessary evil in our situation to get better deals for NASH etc with more credible partners... It is a disgrace though that we need to put up with the likes of Shkreli who is still controling the company, but apparently no one else sees the enormous opportunity with leronlimab and/or is willing to make an appropriate offer...
But let us take a look at the details that will come out soon and for now enjoy the SP reaction today - excited where this will go...
All IMO
I've seen the Netflix documentary "Dirty Money" recently (which was mainly about Valeant Pharma though), and my initial reaction was "What the..." when seeing that Turing was our partner... I hope these questions you put down have been addressed during negotiations and a realistic and fair price tag has been agreed on so that most patients can benefit from it (at least for me, that is important too...)
I see this as a deal with the devil, but as a kind of necessary evil in our situation to get better deals for NASH etc with more credible partners... It is a disgrace though that we need to put up with the likes of Shkreli who is still controling the company, but apparently no one else sees the enormous opportunity with leronlimab and/or is willing to make an appropriate offer...
But let us take a look at the details that will come out soon and for now enjoy the SP reaction today - excited where this will go...
All IMO
1
